The NKTR (Nektar Therapeutics) Active Short Trade reports earnings tomorrow after the close. As to avoid risking a potential gap against the position & possible give-back of profits, I am revising T2, the final target, to current levels (77.06) and closing the trade here for a 28.2% profit. Previous & updated daily charts: